Granules in the improvement of oral heparin bioavailability (original) (raw)
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system
Philippe Maincent
Journal of Controlled Release, 2006
View PDFchevron_right
Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer
Mitchell Wachtel
Drug Development Research, 2006
View PDFchevron_right
Oral heparin: status review
Shingai Majuru
Thrombosis journal, 2006
View PDFchevron_right
Recent advances in search of oral heparin therapeutics
Dr. Shivani Rai Paliwal
Medicinal Research Reviews, 2012
View PDFchevron_right
Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations
Maciej Dryjski
British Journal of Clinical Pharmacology, 1989
View PDFchevron_right
Encapsulation of low molecular weight heparins: Influence on the anti-Xa/anti-IIa ratio
Philippe Maincent
Journal of Controlled Release, 2009
View PDFchevron_right
Novel Nanoparticles for the Oral Delivery of Low Molecular Weight Heparin: In Vitro and in Vivo Assessment
Umamahesh Balekari
Asian Journal of Pharmaceutical and Clinical Research, 2017
View PDFchevron_right
Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects
Fuming Zhang
2000
View PDFchevron_right
Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric Nanoparticles
P. Maincent
Drug Delivery, 2001
View PDFchevron_right
The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin
Kun-ju Lin
Biomaterials, 2009
View PDFchevron_right
Pharmacokinetics of a low molecular weight heparin compared with standard heparin
Thomas Mätzsch
Thrombosis Research, 1986
View PDFchevron_right
Strategies to Overcome Heparins’ Low Oral Bioavailability
Madalena Pinto
Pharmaceuticals, 2016
View PDFchevron_right
Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation
Vaishali Bagalkot
Thrombosis Research, 2006
View PDFchevron_right
Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis
Giangiacomo Torri
Journal of Thrombosis and Haemostasis
View PDFchevron_right
Oral low molecular weight heparin delivery by microparticles from complex coacervation
Philippe Maincent
European Journal of Pharmaceutics and Biopharmaceutics, 2007
View PDFchevron_right
Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties
Giangiacomo Torri
Biochemical Pharmacology
View PDFchevron_right
Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin
Monika Kujdowicz
PLOS ONE, 2015
View PDFchevron_right
Structure and Activity of a New Low-Molecular-Weight Heparin Produced by Enzymatic Ultrafiltration
Fuming Zhang
Journal of Pharmaceutical Sciences, 2014
View PDFchevron_right
Effects on coagulation of a synthetic heparan mimetic given intraperitoneally or orally
Denis Barritault
Journal of Biomedical Materials Research Part A, 2007
View PDFchevron_right
N' alkylamine low molecular mass heparins (LMM-heparin-tyramine and LMM-heparin-tyramine-fitc) exhibit long lasting anticoagulant effects
Job Harenberg
Thrombosis Research, 1995
View PDFchevron_right
Homogeneous low-molecular-weight heparins with reversible anticoagulant activity
truong pham
Nature Chemical Biology, 2014
View PDFchevron_right
Chemical composition, particle size range, and biological activity of some low molecular weight heparin derivatives
Paul Rochon
Journal of Pharmaceutical Sciences, 1990
View PDFchevron_right
Pharmacokinetics of a low molecular weight heparin, Logiparin, after intravenous and subcutaneous administration to healthy volunteers
Thomas Mätzsch
Thrombosis Research, 1991
View PDFchevron_right
Evaluation of the in vitro and in vivo therapeutic equivalence of two pharmaceutically equivalent heparin products
Yasser Bustanji
2011
View PDFchevron_right
“Supersulfated” heparin fragments, a new type of low-molecular weight heparin
Giangiacomo Torri
Biochemical Pharmacology, 1987
View PDFchevron_right
Chemical Microdetermination of Heparin in Plasma
T. Toida
Analytical Biochemistry, 1997
View PDFchevron_right
Comparison of low-molecular weight heparins to unfractionated heparin
Robert Berent
European Heart Journal, 2001
View PDFchevron_right
Recommendations on biosimilar low-molecular-weight heparins
J. Harenberg, Benito Casu, Frederick Ofosu
Journal of Thrombosis and Haemostasis, 2009
View PDFchevron_right
In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits
P. Maincent
Circulation, 2002
View PDFchevron_right
Low-Molecular-Weight Heparins: Are they all the Same?
Jeffrey Ginsberg
British Journal of Haematology, 2003
View PDFchevron_right
Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation
Dr. Shivani Rai Paliwal
International journal of pharmaceutics, 2012
View PDFchevron_right
Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin
Sultan Nacak Baytas
Journal of Medicinal Chemistry, 2021
View PDFchevron_right
Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)—A three way cross-over study in healthy volunteers
Jordi Fontcuberta
Thrombosis Research, 1995
View PDFchevron_right
NOVEL SUBCUTANEOUS SUSTAINED RELEASE NANOPARTICLES ENCAPSULATING LOW MOLECULAR WEIGHT HEPARIN (LMWH): PREPARATION, CHARACTERIZATION AND EVALUATION Original Article
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2016
View PDFchevron_right
Low molecular weight heparin biosimilars: how much similarity for how much clinical benefit?
Ludovic Drouet
Targeted Oncology, 2012
View PDFchevron_right